ClinicalTrials.gov
public full text
Public Domain
Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients
The purpose of this clinical study is to prove that the test drug (TJO-087) is not clinically inferior to the control drug after 32 weeks of administration to patients with suppressed tear production due to moderate or severe dry eye syndrome.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evaluate the Safety and Efficacy of TJO-087#871088
- A Pilot Study of the TearCare System in Adults With Dry Eye Disease#1086930
- Safety/Efficacy of Systane Free vs Refresh Tears#902653
- Efficacy Study of Ketorolac and HPMC to Treat Dry Eye#832328
- Eyelash Prostheses Compared to 5.0% Lifitegrast BID for Dry Eye Disease.#1095506
Record · ID 1075152
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive